| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.652 | 51.635 | 59.109 | 64.969 | 72.082 | 109.570 | 127.762 | 145.635 | 126.397 | 115.103 |
| Total Income - EUR | 7.652 | 51.635 | 59.109 | 64.969 | 72.082 | 109.571 | 127.765 | 145.640 | 126.400 | 115.105 |
| Total Expenses - EUR | 2.122 | 9.745 | 21.123 | 22.067 | 24.534 | 35.977 | 46.169 | 52.249 | 46.766 | 47.217 |
| Gross Profit/Loss - EUR | 5.529 | 41.889 | 37.986 | 42.901 | 47.549 | 73.595 | 81.596 | 93.391 | 79.634 | 67.889 |
| Net Profit/Loss - EUR | 5.300 | 40.931 | 37.395 | 42.252 | 46.828 | 72.499 | 80.318 | 91.935 | 78.370 | 64.436 |
| Employees | 0 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Matymed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 122 | 121 | 119 | 78 | 76 | 1.258 | 2.075 | 3.106 | 3.669 | 2.574 |
| Current Assets | 5.577 | 42.225 | 78.796 | 44.993 | 48.642 | 56.365 | 83.152 | 25.030 | 79.557 | 72.745 |
| Inventories | 0 | 0 | 0 | 183 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.466 | 4.633 | 3.532 | 5.058 | 9.569 | 8.680 | 14.152 | 9.822 | 58.808 | 53.803 |
| Cash | 2.111 | 37.593 | 75.264 | 39.752 | 39.073 | 47.684 | 69.000 | 15.208 | 20.749 | 18.942 |
| Shareholders Funds | 5.345 | 40.976 | 77.677 | 42.303 | 46.878 | 54.142 | 76.910 | 24.458 | 34.459 | 27.684 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 395 | 1.371 | 1.238 | 2.767 | 1.840 | 3.480 | 8.317 | 3.678 | 48.767 | 47.635 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Matymed Srl